During a live event, John S. Renshaw, MD, and other oncologists discussed various trials of novel regimens for patients with ...

2 Combined with advances in medical treatments, an awareness of the underlying disease-causing mechanisms has contributed to a slight decrease in levels of cardiovascular disease risk factors in ...